Strategic and Technical Considerations in Manufacturing Viral Vector Vaccines for the Biomedical Advanced Research and Development Authority Threats
Over the past few decades, the world has seen a considerable uptick in the number of new and emerging infectious disease outbreaks. The development of new vaccines, vaccine technologies, and platforms are critical to enhance our preparedness for biological threats and prevent future pandemics. Viral...
Saved in:
| Main Authors: | Lindsay A. Parish, Shyam Rele, Kimberly A. Hofmeyer, Brooke B. Luck, Daniel N. Wolfe |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Vaccines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2076-393X/13/1/73 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy of different AV7909 dose regimens in a nonclinical model of pulmonary anthrax
by: Lisa Henning, et al.
Published: (2023-12-01) -
Durability of Immunogenicity and Protection of rVSV∆G-ZEBOV-GP Vaccine in a Nonhuman Primate EBOV Challenge Model
by: Sandra L. Bixler, et al.
Published: (2025-02-01) -
Syphilis vaccine development: Aligning vaccine design with manufacturing requirements
by: Sean Waugh, et al.
Published: (2024-12-01) -
Optimising Mechanical Performance of Additive Manufactured Composites for Biomedical Applications
by: Abdul Qadir, et al.
Published: (2025-06-01) -
Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives
by: AbdulRahman A Saied, et al.
Published: (2022-06-01)